Jump to navigation
Join us on 4/23, when you can meet CP3's postdoctoral fellows and learn about their current and future research.
Recent papers from affiliated faculty show importance of training for deprescribing work and identifying it in clinical practice.
On 12/4, we welcomed Stacie Dusetzina, PhD, from Vanderbilt University. This event was co-sponsored by Pitt Public Health, Department of Health Policy and Management.
In a perspective piece in the New England Journal of Medicine, CP3 Director Walid Gellad and HPI Director Everette James describe the controversy surrounding the 340B Drug Pricing Program.Read more.
In a recent article in JAMA, researchers compared prescription opioid use and medication-assisted treatment rates before and after an overdose.
In a recent perspective piece in NEJM, Dr. Gellad discusses the accelerated approval process in the era of expensive drugs. Read more.